Cargando…

Evaluation of lung toxicity with bevacizumab using the spontaneous reporting database

This study was undertaken to determine the risk of bevacizumab-induced lung toxicity, time to onset, and post hoc outcomes using the Japanese Adverse Drug Event Report database. We analysed data for the period between April 2004 and March 2021. Data on lung toxicities were extracted, and relative ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanbayashi, Yuko, Uchida, Mayako, Kashiwagi, Misui, Akiba, Hitomi, Shimizu, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481601/ https://www.ncbi.nlm.nih.gov/pubmed/36114412 http://dx.doi.org/10.1038/s41598-022-19887-x

Ejemplares similares

Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan
por: Kanbayashi, Yuko, et al.
Publicado: (2023)

Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis
por: Kanbayashi, Yuko, et al.
Publicado: (2022)

Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database
por: Niinomi, Iku, et al.
Publicado: (2019)

Drug-induced tubulointerstitial nephritis in a retrospective study using spontaneous reporting system database
por: Oyama, Saki, et al.
Publicado: (2018)

Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting Database
por: Wakabayashi, Tomohito, et al.
Publicado: (2020)

Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database
por: Inada, Ayaka, et al.
Publicado: (2018)

Comprehensive Analysis of Adverse Events Induced by PARP Inhibitors Using JADER and Time to Onset
por: Yamaoka, Kenta, et al.
Publicado: (2022)

Predictive factors for the development of proteinuria in cancer patients treated with bevacizumab, ramucirumab, and aflibercept: a single-institution retrospective analysis
por: Kanbayashi, Yuko, et al.
Publicado: (2020)

Evaluation of Potential Complications of Interstitial Lung Disease Associated With Antiandrogens Using Data From Databases Reporting Spontaneous Adverse Effects
por: Nawa, Hideki, et al.
Publicado: (2021)

Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model
por: Jin, Yinghua, et al.
Publicado: (2018)

Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
por: Toki, Tadashi, et al.
Publicado: (2018)

Effect of Dipeptidyl Peptidase-4 Inhibitors vs. Metformin on Major Cardiovascular Events Using Spontaneous Reporting System and Real-World Database Study
por: Noguchi, Yoshihiro, et al.
Publicado: (2022)

Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects
por: Nawa, Hideki, et al.
Publicado: (2022)

Current Status of Adverse Event Profile of Cyclosporine in Kidney, Stem Cell, and Heart Transplantations Using the Japanese Pharmacovigilance Database
por: Niinomi, Iku, et al.
Publicado: (2022)

Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study
por: Isono-Taniguchi, Roze, et al.
Publicado: (2022)

Real-World Experience in Toxicity with Bevacizumab in Indian Cancer Patients
por: Patil, Pratik P., et al.
Publicado: (2021)

Spontaneous massive duodenal perforation after ovarian cancer treatment with bevacizumab
por: Karanikas, Michael, et al.
Publicado: (2020)

Ramelteon for Delayed Sleep-wake Phase Disorder: A Case Report
por: Takeshima, Masahiro, et al.
Publicado: (2020)

Intravitreal Bevacizumab for Choroidal Metastasis of Lung Carcinoma; a Case Report
por: de la Barquera Cordero, Aída Sánchez, et al.
Publicado: (2010)

Bevacizumab-induced immunoglobulin A vasculitis with nephritis: A case report
por: Endo, Yoko, et al.
Publicado: (2019)

Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)
por: Chien, Chun-Ru, et al.
Publicado: (2012)

Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity
por: Lee, J-M, et al.
Publicado: (2010)

Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
por: Kitchen, D, et al.
Publicado: (2013)

Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature
por: Ishimoto, Hiroshi, et al.
Publicado: (2023)

Inhibitory Effect of α1 Receptor Antagonists on Paclitaxel-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
por: Mori, Kohei, et al.
Publicado: (2022)

Association between Statin Use and Cancer: Data Mining of a Spontaneous Reporting Database and a Claims Database
por: Fujimoto, Mai, et al.
Publicado: (2015)

CASME II: An Improved Spontaneous Micro-Expression Database and the Baseline Evaluation
por: Yan, Wen-Jing, et al.
Publicado: (2014)

Bevacizumab-induced arrhythmia in a patient with lung adenocarcinoma: A case report
por: Li, Jing, et al.
Publicado: (2023)

Spontaneous mesenteric hematoma of the sigmoid colon associated with rivaroxaban: A case report
por: Hirano, Katsuhisa, et al.
Publicado: (2018)

Predicting the side effects of drugs using matrix factorization on spontaneous reporting database
por: Fukuto, Kohei, et al.
Publicado: (2021)

Successful Management of Clozapine-induced Akathisia with Gabapentin Enacarbil: A Case Report
por: Takeshima, Masahiro, et al.
Publicado: (2018)

The genetic toxicity database of the National Toxicology Program: evaluation of the relationships between genetic toxicity and carcinogenicity.
por: Tennant, R W
Publicado: (1991)

Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non–Small-Cell Lung Cancer
por: Reck, Martin, et al.
Publicado: (2020)

Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports
por: Hsu, Ping-Chih, et al.
Publicado: (2023)

Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
por: Mine, Keisuke, et al.
Publicado: (2022)

Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
por: YOKOI, TAKASHI, et al.
Publicado: (2014)

Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation
por: Clément-Zhao, Alice, et al.
Publicado: (2019)

Factors predicting adverse events associated with pregabalin administered for neuropathic pain relief
por: Kanbayashi, Yuko, et al.
Publicado: (2014)

Aripiprazole-induced liver injury: a spontaneous reporting database study
por: Gao, Yunjuan, et al.
Publicado: (2023)

SuperToxic: a comprehensive database of toxic compounds
por: Schmidt, Ulrike, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0pgomu6c0poediqjd833hg40hl